| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
ID: ALA4857145
Max Phase: Preclinical
Molecular Formula: C24H21FN2OS
Molecular Weight: 404.51
Molecule Type: Unknown
Associated Items:
Representations
Canonical SMILES: Cc1ccc(-c2nc(CCc3ccccc3)c(-c3cccc(F)c3O)nc2C)s1
Standard InChI: InChI=1S/C24H21FN2OS/c1-15-11-14-21(29-15)22-16(2)26-23(18-9-6-10-19(25)24(18)28)20(27-22)13-12-17-7-4-3-5-8-17/h3-11,14,28H,12-13H2,1-2H3
Standard InChI Key: YCTSZTFLLOJXER-UHFFFAOYSA-N
Associated Targets(Human)
NR1I2 Tchem Pregnane X receptor (6667 Activities)
CASR Tclin Calcium sensing receptor (766 Activities)
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
Molecule Features
| Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
| Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
| Chirality: No | Availability: No | Prodrug: No |
Drug Indications
| MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
|---|
Mechanisms of Action
| Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
|---|
Properties
| Molecular Weight: 404.51 | Molecular Weight (Monoisotopic): 404.1359 | AlogP: 6.12 | #Rotatable Bonds: 5 |
| Polar Surface Area: 46.01 | Molecular Species: NEUTRAL | HBA: 4 | HBD: 1 |
| #RO5 Violations: 1 | HBA (Lipinski): 3 | HBD (Lipinski): 1 | #RO5 Violations (Lipinski): 1 |
| CX Acidic pKa: 6.92 | CX Basic pKa: | CX LogP: 6.41 | CX LogD: 5.82 |
| Aromatic Rings: 4 | Heavy Atoms: 29 | QED Weighted: 0.44 | Np Likeness Score: -0.73 |
References
| 1. Ramanjulu JM, Williams SP, Lakdawala AS, DeMartino MP, Lan Y, Marquis RW.. (2021) Overcoming the Pregnane X Receptor Liability: Rational Design to Eliminate PXR-Mediated CYP Induction., 12 (9.0): [PMID:34531948] [10.1021/acsmedchemlett.1c00187] |
Source
Source(1):